HELP     Sign In
Search

Relevance to Autism

Deletion of Slc7a5 from the endothelial cells of the blood-brain barrier in mice resulted in an atypical amino acid profile in the brain, abnormal mRNA translation, reduced mIPSC frequency in pyramidal neurons of the somatosensory cortex and cerebellar Purkinje cells, decreased exploratory behavior and locomotion, and abnormalities in social interaction (Tarlungeanu et al., 2016). In the same report, homozygous loss-of-function missense variants in the SLC7A5 gene were identified in two consanguineous families with affected individuals displaying ASD, delays in gross motor, fine motor, and social milestones, delayed or absent language development, and microcephaly or seizures.

Molecular Function

The SLC7A5 gene encodes for a sodium-independent, high-affinity transport of large neutral amino acids such as phenylalanine, tyrosine, leucine, arginine and tryptophan.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.
ASD
Support
The amino acid transporter Slc7a5 regulates the mTOR pathway and is required for granule cell development
Support
Abnormalities in the genes that encode Large Amino Acid Transporters increase the risk of Autism Spectrum Disorder.
ASD
Support
Slc7a5 regulates Kv1.2 channels and modifies functional outcomes of epilepsy-linked channel mutations.
Support
Integrating de novo and inherited variants in 42
ASD
Recent Recommendation
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN860R001a 
 missense_variant 
 c.737C>T 
 p.Ala246Val 
 Familial 
 Both parents 
 Extended multiplex 
 GEN860R002a 
 missense_variant 
 c.1124C>T 
 p.Pro375Leu 
 Familial 
 Both parents 
 Multiplex 
 GEN860R003a 
 missense_variant 
 c.690C>G 
 p.Asn230Lys 
  
 Both parents 
  
 GEN860R004 
 missense_variant 
 c.690C>G 
 p.Asn230Lys 
 Unknown 
  
  
 GEN860R005 
 missense_variant 
 c.690C>G 
 p.Asn230Lys 
 Unknown 
  
  
 GEN860R006 
 missense_variant 
 c.690C>G 
 p.Asn230Lys 
 Unknown 
  
  
 GEN860R007 
 missense_variant 
 c.1123C>A 
 p.Pro375Thr 
 De novo 
  
  
 GEN860R008 
 intron_variant 
 c.816-18C>T 
  
 De novo 
  
  
 GEN860R009 
 intron_variant 
 c.1290+44G>A 
  
 De novo 
  
  
 GEN860R010 
 frameshift_variant 
 c.1511_1523del 
 p.Pro504ArgfsTer112 
 De novo 
  
 Simplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
16
Duplication
 1
 
16
Duplication
 2
 
16
Duplication
 6
 
16
Duplication
 1
 
16
Duplication
 1
 
16
Deletion
 2
 
16
Deletion-Duplication
 3
 
16
Deletion-Duplication
 10
 
16
Deletion
 12
 

Model Summary

Slc7a5 endothelial cell specific conditional knockout mice exhibit abnormal brain amino acid profile, abnormal mRNA translation, hunched posture, hind limb clasping, poor motor coordination, and abnormal gait. The mice also display deficits in social related behaviors, such as rearing behavior, social approach, and reciprocal social interaction. Decreased frequency of mIPSCs and increased amplitude of mEPSCs are observed in the pyramidal neurons in somatosensory cortex or cerebellar Purkinje cells. Intracerebroventricular administration of BCAA partially rescues the motor phenotypes.

References

Type
Title
Author, Year
Primary
Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.

M_SLC7A5_1_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exon 1 of the Slc7a5 gene using Tie2-Cre, in endothelial cells (including those in the brain)
Allele Type: Conditional loss-of-function
Strain of Origin: Not specified
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line: Not specified
Model Source: Not specified

M_SLC7A5_2_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: The Slc7a5-flox;Emx1-Cre conditional line was generated by crossing Slc7a5-flox mouse line (MGI:5618433) with animals expressing the Cre recombinase under the Emx1 promoter (MGI:2684610). In the Slc7a5-flox mouse line, exon 1, including the initiation codon, is flanked by two loxP sites.
Allele Type: Conditional knockout
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_SLC7A5_1_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity1
Decreased
Description: Slc7a5 conditional nulls exhibit decreased locomotor activity (decreased total distance moved and decreased mean velocity) with similar habituation time course relative to heterozygous controls
Exp Paradigm: Open field test: total distance moved and mean velocity
 Open field test
 P55-p65
Gait1
Decreased
Description: Slc7a5 conditional nulls have decreased stride length, increased sway length, and decreased stance length in gait analysis relative to heterozygous controls
Exp Paradigm: Gait
 Gait
 P55-p65
Motor coordination and balance1
Decreased
Description: Slc7a5 conditional nulls have decreased performance in walking beam test relative to heterozygous controls
Exp Paradigm: Balance beam test
 Balance beam test
 P55-p65
Clasping reflex1
Increased
Description: Slc7a5 conditional nulls exhibit hind limb clasping (89% of mutant mice)
Exp Paradigm: Tail suspension test
 Tail suspension test
 NA
Hunched posture1
Increased
Description: Slc7a5 conditional nulls exhibit kyphosis (44% of mutant mice)
Exp Paradigm: General observations
 General observations
 NA
Presynaptic function: vesicle recycling1
Decreased
Description: The presynaptic vesicle number in the inhibitory neurons is decreased in slc7a5 conditional null somatosensory cortices when compared with heterozygous controls
Exp Paradigm: Immunostaining: vesicular gaba transporter (vgat); electron microscopy
 Immunohistochemistry
 Adult
Miniature post synaptic current amplitude: excitatory1
Increased
Description: Slc7a5 conditional nulls exhibit an increase in the amplitude of mepscs
Exp Paradigm: Whole-cell patch clamp: cerebellar purkinje cells
 Whole-cell patch clamp
 P21
Miniature post synaptic current frequency: inhibitory1
Decreased
Description: Slc7a5 conditional nulls exhibit a decrease in the frequency of mepscs
Exp Paradigm: Whole-cell patch clamp: pyramidal neurons in layer 2/3 of the somatosensory cortex
 Whole-cell patch clamp
 P21
Miniature post synaptic current frequency: inhibitory1
Decreased
Description: Slc7a5 conditional nulls exhibit a decrease in the frequency of mepscs
Exp Paradigm: Whole-cell patch clamp: cerebellar purkinje cells
 Whole-cell patch clamp
 P21
Miniature post synaptic current amplitude: excitatory1
Increased
Description: Slc7a5 conditional nulls exhibit an increase in the amplitude of mepscs
Exp Paradigm: Whole-cell patch clamp: pyramidal neurons in layer 2/3 of the somatosensory cortex
 Whole-cell patch clamp
 P21
Social approach1
Decreased
Description: Slc7a5 conditional nulls display no preference to unfamiliar mouse over an object as wildtype controls do
Exp Paradigm: Three-chamber social approach test
 Three-chamber social approach test
 P55-p65
Rearing behavior1
Decreased
Description: Slc7a5 conditional nulls exhibit decreased rearing behavior relative to heterozygous controls
Exp Paradigm: Open field test
 Open field test
 P55-p65
Juvenile play1
Decreased
Description: Slc7a5 conditional nulls tend to stay farther apart from their cagemates and display a decreased number of nose-to-nose contacts relative to wildtype controls
Exp Paradigm: Reciprocal social interaction test
 Reciprocal social interaction test
 P25-p35
Ultrasonic vocalization: isolation induced1
Increased
Description: Slc7a5 conditional nulls exhibit increased ultrasonic vocalization starting from p8 when compared with the littermate wildtype controls
Exp Paradigm: Monitoring ultrasonic vocalizations
 Monitoring ultrasonic vocalizations
 P2-p10
Amino acid levels1
Decreased
Description: Brain amino acid levels of the branched chain amino acids (leucine, isoleucine, and valine) are low in slc7a5 conditional nulls relative to controls (slc7a5fl/fl)
Exp Paradigm: High-performance liquid chromatography (hplc)
 High-performance liquid chromatography (hplc)
 P2-p40
Signaling: amino acid response pathway1
Increased
Description: Slc7a5 conditional nulls exhibit enhanced expression of genes in serine biosynthesis, aminoacyl-trna synthetases, amino acid responsive transcription factors atf4 and atf5, and eukaryotic initiation factor 4e (4ebp1)
Exp Paradigm: Rna sequencing
 Rna sequencing
 Adult
Amino acid levels1
Increased
Description: Brain amino acid levels of histidine, phenylalanine, proline, glycine, threonine, or serine are high in slc7a5 conditional nulls relative to controls (slc7a5fl/fl)
Exp Paradigm: High-performance liquid chromatography (hplc)
 High-performance liquid chromatography (hplc)
 P2-p40
Regulation of translation1
Increased
Description: Slc7a5 conditional nulls exhibit decreased cap-dependent translation initiation
Exp Paradigm: Western blot: p-eif2alpha, 4ebp1; rna sequencing; polysome profiling
 Polysome profiling
 Adult
Gene expression1
Increased
Description: Slc7a5 conditional nulls exhibit enhanced expression of two amino acid transporters, cat1 and cat2 (encoded by slc7a1 or slc7a2, respectively)
Exp Paradigm: Rna sequencing
 Rna sequencing
 Adult
Targeted expression1
Decreased
Description: Slc7a5 conditional nulls display complete deletion of slc7a5 protein in the endothelial cells of the brain blood barrier
Exp Paradigm: Immunostaining
 Immunostaining
 E14.5-p40
Amino acid levels1
 No change
 High-performance liquid chromatography (hplc)
 E14.5, p2-p40
Signaling: mtor1
 No change
 Western blot
 Adult
Cortical lamination1
 No change
 Immunohistochemistry
 Adult
Neuronal number: interneurons1
 No change
 Immunohistochemistry
 Adult
Somatosensory cortical map architecture1
 No change
 Histology
 Adult
Synapse density: inhibitory1
 No change
 Immunostaining
 Adult
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 P21
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 P21
Miniature post synaptic current frequency: excitatory1
 No change
 Whole-cell patch clamp
 P21
Miniature post synaptic current frequency: excitatory1
 No change
 Whole-cell patch clamp
 P21
Neurotransmitter release1
 No change
 Liquid chromatography-mass spectrometry (lc-ms)
 P2-p40
Self grooming: perseveration1
 No change
 General observations
 P55-p65
 Not Reported: Circadian sleep/wake cycle, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Physiological parameters, Seizure, Sensory

M_SLC7A5_2_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Gait1
Decreased
Description: Mutant mice exhibit moderate motor deficits, such as decreased stride and stance length.
 Footprint analysis
 P55-P65
Clasping reflex1
Increased
Description: Mutant mice exhibit hind limb clasping behavior.
 Tail suspension test
 P55-P65
Rearing behavior1
Increased
Description: Mutant mice show increased number of rearings in the open field compared to control mice.
 Open field test
 P55-P65
General locomotor activity: ambulatory activity1
Increased
Description: Mutant mice show increased distance traveled and velocity in the open field compared to control mice.
 Open field test
 P55-P65
Cortical thickness1
Decreased
Description: Histological analysis revealed a reduction in the thickness of the cerebral cortex of P40 Slc7a5 mutant animals, with layers II and III being the drivers of this difference.
 Histology
 P40
Dendritic architecture: spine morphology1
Abnormal
Description: Mutant mice show a decrease in thin spines, increase in stubby spines and no change mushroom-shaped spines.
 Golgi-Cox staining
 P6-7, P40
Brain size1
Decreased
Description: Mutant mice are born with normal brain size. However, by P40, the brain of mutant mice is significantly smaller than that of their control littermates. By monitoring the brain weight over time, we found that the difference in brain size between control and Slc7a5 mutant animals appears during the first postnatal week and remains stable from P10 onward.
 Measurement of tissue weight
 P0-P40
Dendritic architecture: dendritic tree complexity1
Decreased
Description: Number of dendrites is decreased at P6-7 and P40 in mutant mice. At P6-7 there are fewer dendrite intersections at smaller radiuses.
 Golgi-Cox staining
 P6-7, P40
Dendritic architecture: dendritic length1
Decreased
Description: Dendritic length is decreased at P40 but not changed at P6-7 in mutant mice.
 Golgi-Cox staining
 P6-7, P40
Neuronal number: inhibitory neurons1
Decreased
Description: Compared with their littermate controls, adult animals have a significantly lower number of inhibitory neurons, particularly in the upper cortical layers.
 Histology
 P40
Action potential property: firing rate1
Decreased
Description: Recordings from mutant mice show decreased firing rate at P6-7 but not P25-26, compared to control mice.
Exp Paradigm: layers II and III pyramidal neurons from the somatosensory cortex
 Whole-cell current clamp
 P6-P7, P25-26
Amino acid levels: brain1
Abnormal
Description: Amino acids transported by Slc7a5, grouped into the term "aminoacyl-tRNA biosynthesis", are the major class of affected metabolites in conditional knockout animals. However, the deletion of Slc7a5 alters the levels of these amino acids in cortical tissue only at P2, but not E14.5 or P40. The level of these amino acids is higher, not lower, in mutants compared with controls, suggesting that in the absence of Slc7a5, the amino acids accumulate in the extracellular space and are not consumed by neural cells. At P2, intracellular levels of amino acids that are the primary Slc7a5 substrates are indeed significantly reduced in mutant cells.
 High-performance liquid chromatography (HPLC)
 E14.5, P2, P40
Action potential property: firing pattern1
Abnormal
Description: Recordings from mutant mice show altered firing pattern when action potential is plotted as dV/dt vs voltage (phase-plane plot).
Exp Paradigm: layers II and III pyramidal neurons from the somatosensory cortex
 Whole-cell current clamp
 P6-P7, P25-26
Action potential property: threshold1
Decreased
Description: Action potential threshold is decreased at P6-7 in mutant mice compared to control mice.
Exp Paradigm: layers II and III pyramidal neurons from the somatosensory cortex
 Whole-cell current clamp
 P6-P7, P25-26
Action potential property: amplitude1
Increased
Description: Recordings from mutant mice show action potential amplitude is increased compared to control mice.
Exp Paradigm: layers II and III pyramidal neurons from the somatosensory cortex
 Whole-cell current clamp
 P6-P7, P25-26
Intrinsic membrane properties1
Abnormal
Description: P25-26 increase in membrane potential
Exp Paradigm: layers II and III pyramidal neurons from the somatosensory cortex
 Whole-cell current clamp
 P6-P7, P25-26
Action potential property: rate of depolarization1
Decreased
Description: Action potential rise time is decreased at P6-7 in mutant mice compared to control mice.
Exp Paradigm: layers II and III pyramidal neurons from the somatosensory cortex
 Whole-cell current clamp
 P6-P7, P25-26
Amino acid levels: brain1
Abnormal
Description: Amino acids transported by Slc7a5, grouped into the term â??â??aminoacyl-tRNA biosynthesisâ??â??, are the major class of affected metabolites in conditional knockout animals. However, the deletion of Slc7a5 alters the levels of these amino acids in cortical tissue only at P2, but not E14.5 or P40. The level of these amino acids is higher, not lower, in mutants compared with controls, suggesting that in the absence of Slc7a5, the amino acids accumulate in the extracellular space and are not consumed by neural cells. At P2, intracellular levels of amino acids that are the primary Slc7a5 substrates are indeed significantly reduced in mutant cells.
 High-performance liquid chromatography (HPLC)
 E14.5, P2, P40
Social memory1
Decreased
Description: In the three-chamber sociability test, mutant mice show no preference for the chamber with a stranger mouse, whereas control mice explore the chamber with a stranger mouse significantly more than the chamber with a familiar mouse.
 Three-chamber social approach test
 P55-P65
Social approach1
Decreased
Description: In the three-chamber sociability test, mutant mice show no preference for the social stimulus chamber, whereas control mice explore the chamber with a stranger mouse significantly more than the chamber with an inanimate object.
 Three-chamber social approach test
 P55-P65
Bioactive compound levels: phospholipid1
Decreased
Description: However, we found that loss of Slc7a5 in neurons affects the levels of metabolites related to glycerophospholipids (GPLs). Specifically, an analysis of all the detected lipid-related metabolites disclosed that while at E14.5 and P40 mutant and control samples cluster together, P2 samples separate by genotype. A comparative untargeted lipidomic analysis of P2 mutant and control cortical tissue and dissociated cells reveals a specific reduction of GPLs in mutant cortical cells. Members of the GPLs are the main components of the phospholipid bilayer of biological membranes.
 High-performance liquid chromatography (HPLC)
 E14.5, P2, P40
Bioactive compound levels: fatty acid1
Increased
Description: The comparative untargeted lipidomic analysis of P2 mutant and control cortical tissue and dissociated cells that reveals a specific reduction of GPLs in mutant cortical cells, also shows an increase of triacylglycerols (TGs) in Slc7a5 deficient cortical tissue. TGs account for the majority of dietary fats and represent a way to store energy.
 High-performance liquid chromatography (HPLC)
 E14.5, P2, P40
Proteomic profile diversity1
Abnormal
Description: In a proteomic study of perinatal control and mutant cerebral cortices, 1,202 proteins were identified to be deregulated in mutant samples, comprising 954 upregulated and 248 downregulated proteins in the conditional knockout cortex. Gene ontology (GO) enrichment analysis returned proteins involved in lipid metabolism as being the most significant and numerous among the upregulated proteins, while among the downregulated GO terms, an enrichment for neuron projection and membrane-associated proteins was found.
 High-performance liquid chromatography (HPLC)
 E14.5, P2, P40
Protein modification process1
Abnormal
Description: Three palmitoyltransferases are deregulated in Slc7a5 mutants. These include a reduction in Zdhhc17, which specifically modifies proteins involved in neuronal functions.
 Western blot
 Unreported
Apoptosis1
Increased
Description: Protein level of cleaved caspase-3, a pro-apoptotic marker, was increased in cortical samples obtained from mutant mice compared to control mice. A significant increase in cleaved caspase-3 was specifically seen at P2 and P5.
 Western blot
 P2-P5
Targeted expression1
Decreased
Description: Conditional knockout mice show reduced expression of Slc7a5 protein in the brain, including the excitatory neurons of the neocortex and hippocampus as well as in the glial cells of the pallium, but not in the endothelial cells of the BBB.
 Immunohistochemistry
 E14.5, P2, P40
Mortality/lethality1
 No change
 General observations
 P0
Size/growth1
 No change
 Body weight measurement
 P0
Anxiety1
 No change
 Open field test
 P55-P65
Signaling1
 No change
 Western blot
 E14.5, P2, P40
Dendritic architecture: spine density1
 No change
 Golgi-Cox staining
 P6-7, P40
Action potential property: half-width1
 No change
 Whole-cell current clamp
 P6-P7, P25-26
Action potential property: rate of repolarization1
 No change
 Whole-cell current clamp
 P6-P7, P25-26
Homeostasis1
 No change
 High-performance liquid chromatography (HPLC)
 E14.5, P2, P40
 Not Reported:

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.